A New Era for Cancer Research: The Mark Foundation's 2025 Awards
The Mark Foundation for Cancer Research proudly recognizes the outstanding contributions of early-career scientists through its 2025 Emerging Leader Awards. These awards spotlight five exceptional researchers who are dedicated to revolutionizing the landscape of cancer research with their innovative and high-impact projects. Collectively, they will receive $3.75 million to advance their groundbreaking work aimed at transforming cancer treatment.
The Vision Behind the Awards
"At The Mark Foundation, we believe that investing in the next generation of scientists is essential for fostering new perspectives and ideas in cancer research," expressed Ryan Schoenfeld, PhD, CEO of The Mark Foundation. He emphasized the importance of these emerging leaders in pursuing bold approaches that could lead to significant advancements in cancer treatment across various tumor types. This year’s awardees exemplify exceptional talent and vision as they embark on their innovative journeys.
Diverse Research Goals of the Awardees
The recipients of the 2025 Emerging Leader Awards are tackling a range of critical research challenges. Their projects span various aspects of cancer biology and treatment methods, focusing specifically on:
- Investigating the co-evolution of tumor and stromal cells
- Developing immunoprevention strategies for individuals at high risk
- Identifying metabolic vulnerabilities in brain cancer
- Creating new therapeutics aimed at oncogenic fusions
- Engineering synthetic T cell states for enhancing immunotherapies
Meet the 2025 Emerging Leader Award Recipients
The 2025 Emerging Leader Award recipients include:
Liron Bar-Peled, PhD
Mass General Cancer Center
Dr. Bar-Peled is developing "molecular staples," a pioneering class of drugs that disrupt oncogenic fusion proteins—gene pairs that link abnormally and drive the progression of various cancers.
Kai Kessenbrock, PhD
University of California, Irvine
Dr. Kessenbrock's research investigates how inherited BRCA1 mutations alter breast tissue and the immune landscape, potentially influencing breast cancer initiation.
Ansuman Satpathy, MD, PhD
Stanford University
He is engineering T cell states with enhanced anti-cancer properties using synthetic transcription factors designed to regulate gene expression.
Mara Sherman, PhD
Memorial Sloan Kettering Cancer Center
Dr. Sherman is working on understanding how cancer-associated fibroblasts contribute to tumor development and therapeutic resistance in pancreatic cancer.
Daniel Wahl, MD, PhD
University of Michigan Rogel Cancer Center
Dr. Wahl seeks to characterize how glioblastoma cells obtain nutrients from surrounding healthy cells, which may lead to novel treatment strategies for brain cancer.
Funding and Impact
Each 2025 Emerging Leader Award includes $750,000 in funding, which is allocated as $250,000 per year over a period of three years. Since the program was launched in 2018, it has awarded over $37 million to empower early-career scientists.
About The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research is a leading charitable organization that collaborates with scientists across the globe to fast-track advancements in cancer prevention, diagnosis, and treatment. With over $250 million granted to researchers affiliated with more than 100 academic institutions in 16 countries, the Foundation supports early-career scientific endeavors, fosters collaboration in team science, and promotes the discovery of novel technologies and therapeutics.
For more information about the Emerging Leader Award program and the 2025 recipients, please visit The Mark Foundation's official website.
Frequently Asked Questions
What is the Emerging Leader Award program?
The Emerging Leader Award program recognizes and supports early-career scientists conducting innovative cancer research through substantial funding.
How much funding do recipients receive?
Each awardee receives a total of $750,000, distributed over three years, to support their research projects.
Who are the 2025 Emerging Leader Award recipients?
The recipients include Liron Bar-Peled, Kai Kessenbrock, Ansuman Satpathy, Mara Sherman, and Daniel Wahl, each recognized for their groundbreaking research.
What are the research areas covered by the awardees?
The awardees focus on various cancer research areas, including tumor evolution, immunoprevention, brain cancer vulnerabilities, and enhancing immunotherapy efficacy.
What impact has the program had since its inception?
Since its establishment, the Emerging Leader Awards program has provided over $37 million in funding to foster innovative research led by early-career scientists.
